Page last updated: 2024-10-27

fluconazole and Peripheral Arterial Disease

fluconazole has been researched along with Peripheral Arterial Disease in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wils, J1
Djerada, Z1
Roca, F1
Duflot, T1
Iacob, M1
Remy-Jouet, I1
Joannides, R1
Bellien, J1

Other Studies

1 other study available for fluconazole and Peripheral Arterial Disease

ArticleYear
Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging.
    Atherosclerosis, 2018, Volume: 275

    Topics: Adult; Age Factors; Aged; Aging; Cytochrome P-450 Enzyme Inhibitors; Eicosanoids; Endothelium, Vascu

2018